Fabian Finkelmeier
AuthID: R-00K-HMS
1
TÃTULO: Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population Full Text
AUTORES: Casadei Gardini, Andrea; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Rimassa, Lorenza; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; ...Mais
PUBLICAÇÃO: 2023, FONTE: EUROPEAN JOURNAL OF CANCER, VOLUME: 180
AUTORES: Casadei Gardini, Andrea; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Rimassa, Lorenza; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; ...Mais
PUBLICAÇÃO: 2023, FONTE: EUROPEAN JOURNAL OF CANCER, VOLUME: 180
INDEXADO EM: Scopus WOS
2
TÃTULO: Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis? Full Text
AUTORES: Rimini, Margherita; Persano, Mara; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Piscaglia, Fabio; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; ...Mais
PUBLICAÇÃO: 2023, FONTE: TARGETED ONCOLOGY
AUTORES: Rimini, Margherita; Persano, Mara; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Piscaglia, Fabio; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; ...Mais
PUBLICAÇÃO: 2023, FONTE: TARGETED ONCOLOGY
INDEXADO EM: Scopus WOS
3
TÃTULO: Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab Full Text
AUTORES: Persano, Mara; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa Ramos, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Stefanini, Bernardo; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; ...Mais
PUBLICAÇÃO: 2023, FONTE: ONCOLOGY, VOLUME: 101, NÚMERO: 5
AUTORES: Persano, Mara; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa Ramos, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Stefanini, Bernardo; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; ...Mais
PUBLICAÇÃO: 2023, FONTE: ONCOLOGY, VOLUME: 101, NÚMERO: 5
INDEXADO EM: Scopus WOS
4
TÃTULO: Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index
AUTORES: Persano, M; Rimini, M; Tada, T; Suda, G; Shimose, S; Kudo, M; Cheon, J; Finkelmeier, F; Lim, HY; Presa, J; Masi, G; Yoo, C; Lonardi, S; Pressiani, T; Piscaglia, F; Kumada, T; Rimassa, L; Scartozzi, M; Cascinu, S; Casadei Gardini, A; ...Mais
PUBLICAÇÃO: 2023, FONTE: ANTICANCER RESEARCH, VOLUME: 43, NÚMERO: 4
AUTORES: Persano, M; Rimini, M; Tada, T; Suda, G; Shimose, S; Kudo, M; Cheon, J; Finkelmeier, F; Lim, HY; Presa, J; Masi, G; Yoo, C; Lonardi, S; Pressiani, T; Piscaglia, F; Kumada, T; Rimassa, L; Scartozzi, M; Cascinu, S; Casadei Gardini, A; ...Mais
PUBLICAÇÃO: 2023, FONTE: ANTICANCER RESEARCH, VOLUME: 43, NÚMERO: 4
INDEXADO EM: Scopus WOS
5
TÃTULO: Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients
AUTORES: Margherita Rimini; Mara Persano; Toshifumi Tada; Goki Suda; Shigeo Shimose; Masatoshi Kudo; Jaekyung Cheon; Fabian Finkelmeier; Ho Yeong Lim; José Presa; Francesca Salani; Sara Lonardi; Fabio Piscaglia; Takashi Kumada; Naoya Sakamoto; Hideki Iwamoto; Tomoko Aoki; Hong Jae Chon; Vera Himmelsbach; Marta Schirripa; ...Mais
PUBLICAÇÃO: 2023, FONTE: Journal of Cancer Research and Clinical Oncology
AUTORES: Margherita Rimini; Mara Persano; Toshifumi Tada; Goki Suda; Shigeo Shimose; Masatoshi Kudo; Jaekyung Cheon; Fabian Finkelmeier; Ho Yeong Lim; José Presa; Francesca Salani; Sara Lonardi; Fabio Piscaglia; Takashi Kumada; Naoya Sakamoto; Hideki Iwamoto; Tomoko Aoki; Hong Jae Chon; Vera Himmelsbach; Marta Schirripa; ...Mais
PUBLICAÇÃO: 2023, FONTE: Journal of Cancer Research and Clinical Oncology
INDEXADO EM: Scopus
6
TÃTULO: Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients Full Text
AUTORES: Persano, Mara; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; ...Mais
PUBLICAÇÃO: 2023, FONTE: EUROPEAN JOURNAL OF CANCER, VOLUME: 189
AUTORES: Persano, Mara; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; ...Mais
PUBLICAÇÃO: 2023, FONTE: EUROPEAN JOURNAL OF CANCER, VOLUME: 189
INDEXADO EM: Scopus WOS
7
TÃTULO: Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments
AUTORES: Persano, Mara; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shigeo, Shimose; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Piscaglia, Fabio; Iavarone, Massimo; Di Costanzo, Giuseppe; Marra, Fabio; Cabibbo, Giuseppe; Foschi, Francesco; Siletta, Marianna; Cascinu, Stefano; ...Mais
PUBLICAÇÃO: 2023, FONTE: JOURNAL OF HEPATOLOGY, VOLUME: 78
AUTORES: Persano, Mara; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shigeo, Shimose; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Piscaglia, Fabio; Iavarone, Massimo; Di Costanzo, Giuseppe; Marra, Fabio; Cabibbo, Giuseppe; Foschi, Francesco; Siletta, Marianna; Cascinu, Stefano; ...Mais
PUBLICAÇÃO: 2023, FONTE: JOURNAL OF HEPATOLOGY, VOLUME: 78
INDEXADO EM: WOS
8
TÃTULO: Survival outcomes from Atezolizumab plus Bevacizumab versus Lenvatinib versus Sorafenib in Child Pugh B unresectable hepatocellular carcinoma patients
AUTORES: Rimini, Margherita; Persano, Mara; Tada, Toshifumi; Suda, Goki; Shigeo, Shimose; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Lonardi, Sara; Piscaglia, Fabio; Chon, Hong Jae; Masi, Gianluca; Scartozzi, Mario; Cascinu, Stefano; Casadei Gardini, Andrea;
PUBLICAÇÃO: 2023, FONTE: JOURNAL OF HEPATOLOGY, VOLUME: 78
AUTORES: Rimini, Margherita; Persano, Mara; Tada, Toshifumi; Suda, Goki; Shigeo, Shimose; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Lonardi, Sara; Piscaglia, Fabio; Chon, Hong Jae; Masi, Gianluca; Scartozzi, Mario; Cascinu, Stefano; Casadei Gardini, Andrea;
PUBLICAÇÃO: 2023, FONTE: JOURNAL OF HEPATOLOGY, VOLUME: 78
INDEXADO EM: WOS
9
TÃTULO: α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma Full Text
AUTORES: Rossari, Federico; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Yoo, Changhoon; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Bergamo, Francesca; Amadeo, Elisabeth; Vitiello, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; ...Mais
PUBLICAÇÃO: 2023, FONTE: INTERNATIONAL JOURNAL OF CANCER
AUTORES: Rossari, Federico; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Yoo, Changhoon; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Bergamo, Francesca; Amadeo, Elisabeth; Vitiello, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; ...Mais
PUBLICAÇÃO: 2023, FONTE: INTERNATIONAL JOURNAL OF CANCER
INDEXADO EM: Scopus WOS
10
TÃTULO: Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: A large, real-life, worldwide population.
AUTORES: Rimini, Margherita; Casadei Gardini, Andrea; Persano, Mara; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Rimassa, Lorenza; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Scartozzi, Mario; Burgio, Valentina; Cascinu, Stefano; Cucchetti, Alessandro;
PUBLICAÇÃO: 2023, FONTE: Genitourinary Cancers Symposium in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 41
AUTORES: Rimini, Margherita; Casadei Gardini, Andrea; Persano, Mara; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Rimassa, Lorenza; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Scartozzi, Mario; Burgio, Valentina; Cascinu, Stefano; Cucchetti, Alessandro;
PUBLICAÇÃO: 2023, FONTE: Genitourinary Cancers Symposium in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 41
INDEXADO EM: WOS